Bank of America upgrades Sabra Health Care REIT to buy

Bank of America has upgraded shares of Sabra Health Care REIT to a buy rating from neutral, according to Ticker Report.

Advertisement

Bank of America has a $28.50 target price on the stock. Sabra Health Care has a one-year low of $24.01 and a one-year high of $31.17.

In Sabra Health Care’s last available quarterly earnings data, which was issued on July 30, the company reported $0.57 earnings per share for the quarter.

More articles on healthcare finance:

For-profit hospital stock report: Week of Oct. 13-17
Moody’s upgrades St. Joseph’s Healthcare System’s rating to ‘Baa3’
How reducing healthcare spending affects economic growth: 4 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Capital

Advertisement

Comments are closed.